Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-01

Clinical Trial Update: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 trial of mycophenolate mofetil in IgA nephropathy was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: IgA Nephropathy | Phase 3 | Status: TERMINATED | Results posted: 2014-10-01